Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Gangolli Julian S
   2. Issuer Name and Ticker or Trading Symbol
ALLERGAN INC [AGN] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CVP & Pres, North America
(Last)
(First)
(Middle)
2525 DUPONT DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
11/27/2012
(Street)

IRVINE, CA 92612		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/27/2012   M   4,622 A $ 58.55 20,402.637 D  
Common Stock 11/27/2012   M   30,000 A $ 40.16 50,402.637 D  
Common Stock 11/27/2012   S   34,622 D $ 92.2533 (1) 15,780.637 D  
Common Stock 11/28/2012   M   55,378 A $ 58.55 71,158.637 D  
Common Stock 11/28/2012   S   55,378 D $ 91.66 (2) 15,780.637 D (3)  
Common Stock               219.6364 I By ESOP Trust (4)
Common Stock               12,172 I By The Gangolli Family Trust (5)
Common Stock               264.0416 I By Wife's 401(k) plan

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $ 58.55 11/27/2012   M     4,622   (6) 02/02/2017 Common Stock 4,622 $ 0 55,378 D  
Employee Stock Option (Right to Buy) $ 40.16 11/27/2012   M     30,000   (7) 02/20/2019 Common Stock 30,000 $ 0 15,000 D  
Employee Stock Option (Right to Buy) $ 58.55 11/28/2012   M     55,378   (6) 02/02/2017 Common Stock 55,378 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Gangolli Julian S
2525 DUPONT DRIVE
IRVINE, CA 92612		       CVP & Pres, North America  

Signatures

 /s/ Matthew J. Maletta, attorney-in-fact for Julian S. Gangolli   11/29/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $92.25 to $92.31, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
(2) The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.34 to $91.88, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
(3) Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
(4) Shares allocated to the reporting person's ESOP account as of reporting date.
(5) Shares held by The Gangolli Family Trust established June 1, 2011, of which the reporting person and his spouse are each trustees.
(6) The option became exercisable in four equal annual installments beginning February 2, 2008.
(7) The option became exercisable in four equal annual installments beginning February 20, 2010. The remaining outstanding options for this award are reported in this filing.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.